financetom
Business
financetom
/
Business
/
US FDA approves Ionis Pharma's genetic disorder drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Ionis Pharma's genetic disorder drug
Dec 19, 2024 2:30 PM

Dec 19 (Reuters) - The U.S. Food and Drug Administration

has approved Ionis Pharmaceuticals' ( IONS ) drug to treat a

rare genetic disorder, making it the company's first wholly

owned drug, the health regulator's website showed on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved